Imaging of COVID-19: An update of current evidences - 02/09/21
, Yoshinobu Ishiwata a, Ryo Aoki b, Tae Iwasawa c, Eri Hagiwara d, Takashi Ogura d, Daisuke Utsunomiya a
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | Infection control inside CT suites is very important in the era of COVID-19. |
• | Alveolar collapse and vascular enlargement can be clearly detected by ultra-high resolution computed tomography. |
• | Cardiac MRI is useful to detect cardiac involvement in patients with COVID-19. |
• | Artificial intelligence may improve the diagnostic process and quantification of disease severity in patients with COVID-19. |
Abstract |
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been reported as a global emergency. As respiratory dysfunction is a major clinical presentation of COVID-19, chest computed tomography (CT) plays a central role in the diagnosis and management of patients with COVID-19. Recent advances in imaging approaches using artificial intelligence have been essential as a quantification and diagnostic tool to differentiate COVID-19 from other respiratory infectious diseases. Furthermore, cardiovascular involvement in patients with COVID-19 is not negligible and may result in rapid worsening of the disease and sudden death. Cardiac magnetic resonance imaging can accurately depict myocardial involvement in SARS-CoV-2 infection. This review summarizes the role of the radiology department in the management and the diagnosis of COVID-19, with a special emphasis on ultra-high-resolution CT findings, cardiovascular complications and the potential of artificial intelligence.
Le texte complet de cet article est disponible en PDF.Keywords : COVID-19, Computed tomography, Cardiac magnetic resonance, Artificial intelligence, Pulmonary embolism
Abbreviations : ACE2, COVID-19, CO-RADS, CT, DVT, MRI, PCR, PE, PPE, RT, SARS-CoV-2, U-HRCT, VTE
Plan
Vol 102 - N° 9
P. 493-500 - septembre 2021 Retour au numéro
Article précédent
- COVID-19 after 18 months: Where do we stand?
- Guillaume Chassagnon, Lucile Regard, Philippe Soyer, Marie-Pierre Revel
- Focal splenic lesions: Imaging spectrum of diseases on CT, MRI and PET/CT
- Maxime Barat, Christine Hoeffel, Mathilde Aissaoui, Anthony Dohan, Amar Oudjit, Raphael Dautry, Anita Paisant, Brice Malgras, Anne-Ségolène Cottereau, Philippe Soyer
Bienvenue sur EM-consulte, la référence des professionnels de santé.